- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
TransMedics Group Inc. Aktie
Verkaufen
Kaufen
TransMedics Group Inc. Chart
TransMedics Group Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-4,64 %
Intraday
-0,32 %
1 Woche
15,03 %
1 Monat
15,40 %
Seit Jahresbeginn
-13,46 %
1 Jahr
471,94 %
3 Jahre
288,71 %
5 Jahre
Wikifolio
Passender Service zu TransMedics Group Inc.
Webinar zu TransMedics Group Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)55,000-177,370
- Jahrestief / Hoch ($)55,000-82,370
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von TransMedics Group Inc.
Keine Dividenden verfügbar
Termine von TransMedics Group Inc.
- Feb27TransMedics Group Inc.Q4 2024 Earnings Release
- Mai6TransMedics Group Inc.Q1 2025 Earnings Release
- Jul31TransMedics Group Inc.Q2 2025 Earnings Release
Beschreibung
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
